Last week, Scandinavian Medical Solutions adjusted its 2024/25 guidance downward due to increased geopolitical uncertainties and threats of tariffs. Both prolonging customers' decision process. We have updated our investment case one-pager following the new guidance for 2024/25. Besides an overview of financials and valuation multiples in perspective to peers, the investment case one-pager introduces Scandinavian Medical Solutions and highlights key investment reasons and risks.
Earlier this week, the management of Scandinavian Medical Solutions presented the reasons behind the downgrade and what is done to mitigate that in an online live event (in Danish). Watch the presentation here: https://www.inderes.dk/videos/scandinavian-medical-solutions-praesentation-af-nedjusterede-forventninger-til-202425-og-qanda
Disclaimer: HC Andersen Capital receives payment from Scandinavian Medical Solutions for a Digital IR/Corporate Visibility subscription agreement. /Michael Friis 09:30, 27-03-2025.
This content is only available for logged in users